Wiley Blackwell

SHERPA: Unknown

People

  1. Zelenetz
    Zelenetz
  2. Hamlin
    Hamlin
  3. Horwitz
    Horwitz
  4. Kumar
    Kumar
  5. Moskowitz
    Moskowitz
  6. Noy
    Noy
  7. Palomba
    Palomba
  8. Yahalom
    Yahalom
  9. Caron
    Caron
  10. Salles
    Salles

Groups

  1. Center for Hematologic Malignancies (9)
  2. Department of Medicine (9)
  3. Hematologic Malignancies, Division of (9)
  4. Lymphoma (9)
  5. Sloan Kettering Institute Postdocs (9)
  6. Survivorship Research (9)
  7. Population Sciences Research Program (8)
  8. Epidemiology and Biostatistics (6)
  9. Executive Committee, Center for Hematologic Malignancies (6)
  10. Radiation Oncology, Department of (6)
Search Within
  1. "Sloan Kettering Institute Postdocs"
  2. "Andrew Zelenetz"
Formats
  1. Meeting Abstract (9)
Groups
  1. Center for Hematologic Malignancies (9)
  2. Department of Medicine (9)
  3. Hematologic Malignancies, Division of (9)
  4. Lymphoma (9)
  5. Sloan Kettering Institute Postdocs (9)
  6. Survivorship Research (9)

More Groups

People
  1. Andrew Zelenetz (9)
  2. Alison Moskowitz (8)
  3. Anita Kumar (8)
  4. Ariela Noy (8)
  5. David Straus (8)
  6. Maria Palomba (8)

More People

Years
  1. 2023 (3)
  2. 2021 (1)
  3. 2019 (3)
  4. 2017 (2)
Publications
  1. Hematological Oncology (9)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PET‐adapted therapy with nivolumab plus adriamycin, vinblastine, and dacarbazine for newly diagnosed stage III or IV Hodgkin Lymphoma
    Meeting Abstract

    Moskowitz, A.; Savage, K.; Feldman, T.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Genetic alterations in follicular lymphoma predict response to very low dose radiotherapy
    Meeting Abstract

    Wijetunga, N. A.; Lebow, E.; Chan, A.; Lee, J.; Fregonese, B.; Hajj, C.; Cedarquist, G.; Hubbeling, H.; Ma, J.; Sarkar, R.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of nivolumab plus adriamycin, vinblastine, dacarbazine (N‐AVD) as frontline therapy in older adults with Hodgkin lymphoma
    Meeting Abstract

    Torka, P.; Feldman, T.; Savage, K.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Clinical outcomes and the role of observation in early‐stage follicular lymphoma
    Meeting Abstract

    Sha, F.; Okwali, M.; Alperovich, A.; Caron, P. C.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; Kumar, A.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • Incidence and treatment outcomes of patients with transformed marginal zone lymphoma treated with RCHOP‐like regimens
    Meeting Abstract

    Rajeeve, S.; Bobillo, S. V.; Zelenetz, A. D.; Straus, D. J.; Palomba, M. L.; Noy, A.; Horwitz, S. M.; Moskowitz, A. J.; Hamlin, P. A.; Matasar, M. J.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of stage I diffuse large B cell lymphoma (DLBCL) in the rituximab‐era
    Meeting Abstract

    Bobillo, S.; Joffe, E.; Lavery, J.; Noy, A.; Palomba, L.; Straus, D. J.; Kumar, A.; Batlevi, C.; Horwitz, S.; Moskowitz, A.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Impact of pet imaging and histologic transformation on the prognosis of early disease progression in follicular lymphoma
    Meeting Abstract

    Batlevi, C. L.; Sha, F.; Alperovich, A.; Ni, A.; Smith, K.; Ying, Z.; Hamlin, P.; Horwitz, S. M.; Kumar, A.; Matasar, M.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Defining progression free survival after multiple lines of therapy and impact of dynamic changes in FLIPI for multiply relapsed follicular lymphoma in the rituximab era
    Meeting Abstract

    Batlevi, C.; Alperovich, A.; Ni, A.; Soumerai, J.; Smith, K.; Ying, Z.; Caron, P.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Time from prognosis to 2nd treatment is a promising surrogate for overall survival in patients with advanced stage follicular lymphoma
    Meeting Abstract

    Soumerai, J. D.; Ni, A.; Batlevi, C.; Alperovich, A.; Bantilan, K. S.; Palomba, M.; Gerecitano, J. F.; Noy, A.; Hamlin, P.; Moskowitz, C. H.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save